Patent · US Active

Use of miR-21 in preparation of drug for treating intrauterine adhesion and/or thin endometrium

US11471541B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2018
Grant dateOct 18, 2022
Priority date—
Expiry dateFeb 12, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is use of miR-21 in preparation of a therapeutic drug or diagnostic reagent for intrauterine adhesion and/or thin endometrium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.